Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

J. Molina Collada, Fernando Sánchez‐Alonso, Lucia Otero Varela, C. Bohórquez Heras, Cèsar Díaz‐Torné, Carolina Pérez-García, J. M. Blanco Madrigal, Paloma Vela, José María Álvaro‐Gracia, Isabel Castrejón